The purpose of this investigation was to study apparatus-dependent dose distribution differences specific to spine stereotactic body radiotherapy (SBRT) treatment planning. This multi-institutional study was performed evaluating an image-guided robotic radiosurgery system (CK), intensity modulated protons (IMP), multileaf collimator (MLC) fixed-field IMRT with 5 mm (11 field), 4 mm (9 field), and 2.5 mm (8-and 9-field) leaf widths and intensity modulated volumetric arc therapy (IMVAT) with a 2.5 mm MLC. Treatment plans were systematically developed for targets consisting of one, two and three consecutive thoracic vertebral bodies (VBs) with the esophagus and spinal cord contoured as the organs at risk. It was found that all modalities achieved acceptable treatment planning constraints. However, following normalization fixed field IMRT with a 2.5 mm MLC, IMVAT and IMP systems yielded the smallest ratio of maximum dose divided by the prescription dose (MD/PD) for one-, twoand three-VB PTVs (ranging from 1.1-1.16). The 2.5 mm MLC 9-field IMRT, IMVAT and CK plans resulted in the least dose to 0.1 cc volumes of spinal cord and esophagus. CK plans had the greatest degree of target dose inhomogeneity. As the level of complexity increased with an increasing number of vertebral bodies, distinct apparatus features such as the use of a high number of beams and a finer leaf size MLC were favored. Our study quantified apparatus-dependent dose-distribution differences specific to spine SBRT given strict, but realistic, constraints and highlights the need to benchmark physical dose distributions for multi-institutional clinical trials.
Introduction
Spine stereotactic body radiotherapy (SBRT) has emerged as an appealing option for treating spinal tumors despite the proximity of critical structures such as spinal cord and esophagus (1) . Different techniques and modalities have been considered for spine SBRT (1) (2) (3) (4) (5) (6) (7) (8) (9) and, predominantly, include: (i) a non-isocentric X-band linear accelerator using a robotic arm with six-degrees of freedom beam direction manipulation and superposition (Cyberknife, Accuray, Sunnyvale, CA, USA) (3, 8, (10) (11) (12) (13) (14) and (ii) isocentric S-band linear accelerators using a multi-leaf collimator (MLC) for beam shaping and intensity modulation (4, 6, 9, 15, 16) . Proton therapy with range and intensity modulation is a potential technology for this application (17, 18) , though it has not yet been used clinically for this indication nor has dosimetric feasibility yet been reported.
The dose delivery paradigm differs for the above mentioned modalities and key features are summarized in Table 1 . In brief, the Cyberknife apparatus relies on a set of fixed beams (1 to 3) cross-firing from a large number (~100-200) of angles to achieve the desired dose distribution (19) . On the other hand, MLC-equipped linear accelerators overlap a high number (~60-300) of shaped-beam apertures from just a few (~5-10) beam angles to achieve the desired dose distribution. Current developments in MLC-based delivery include intensity modulated volumetric arc therapy (IMVAT), which is a form of rotational IMRT (20) . IMVAT is achieved by combining dynamic gantry motion with beam intensity modulation where the entire treatment is delivered in a single (or multiple) gantry rotation(s), resulting in a significantly shorter treatment delivery time (20, 21) . The Varian IMVAT platform is termed RapidArc © (Varian Medical Systems, Palo Alto, CA, USA) and treatment plans were generated with a 2.5 mm MLC leaf width for this study. Proton therapy uses a limited number of beams (~1-3) to achieve the dose distribution relying primarily on range modulation of the Bragg peak. Beam spot scanning technology allows range modulation and intensity modulated proton (IMP) delivery. Because of the differences inherent to each technology, benchmarking the physical dose distributions for spine SBRT is needed to ensure consistency for multi-institutional clinical trials that allow various SBRT platforms. In addition, benchmarking 
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cases must be selected with care given that most SBRT modalities are likely to demonstrate equal performance capability such as, all pass, or all fail, if cases are either too simple or too complex.
We designed and conducted a multi-institutional treatment planning study for a set of three spine cases, where the degree of difficulty in the dose-volume constraints was systematically elevated by design. The goal of our study was to determine possible apparatus-dependent dosimetric differences based on modalities for spine SBRTcurrently in clinical use at each of the authors institutions, and to also evaluate the potential for IMP for spine SBRT recognizing this application has yet to be realized in the clinic.
Materials and Methods
Healthy thoracic vertebral bodies (VBs) from T4-T6 were selected as targets for the purposes of this study, and were imaged with a single non-contrast body CT that extended from C1 to L5 with 1.25 mm spacing. Planning target volumes (PTVs) of one (T6), two (T5-6) or three (T4-6) consecutive VB lengths were contoured by a single radiation oncologist. The full VB length was outlined as the PTV and the organs-at-risk consisted of the esophagus and the spinal cord (the latter contoured per the thecal sac (22)). A thecal sac length of approximately 15.2 cm from T2 to T8 level was contoured for planning and evaluation purpose for all three cases. Transverse process and posterior elements were not included in the target volume (representative dose distributions are provided in Figure 1 for the one VB target for selected modalities and the PTV in red thick outline). The CT images and contours were distributed as DICOM-RT studies to the participating institutions for treatment planning.
At each institution, separate treatments plans were developed for PTV volumes that encompassed one VB (T6), two consecutive VBs (T5 and T6) and three consecutive VBs (T4, T5, and T6). For all plans, dose volume constraints were specified as follows: (1) at least 90% of the PTV to receive 2400 cGy in 3 fractions, (2) no more than 0.1 cc of thecal sac to receive ≥1000 cGy, (3) the maximum point volume dose to the thecal sac <1200 cGy, (4) no more than 0.1 cc of esophagus to receive ≥1800 cGy and (5) the maximum point dose to the esophagus <2000 cGy. The cord and esophagus constraints were stipulated as being strict, and given priority at the expense of target coverage though within 5-7% of any specified values. A maximum dose within the PTV was not specified as dose homogeneity practice varies considerably for spine SBRT. For example, the published spine SBRT experience from the University of California San Francisco (UCSF) reported prescription isodose lines ranging from 44-84% to ensure target coverage, and maximum target point doses up to 80 Gy were allowed in 3-5 fractions (3). Lastly, compromising the PTV coverage was deemed acceptable in the study protocol to respect the strict dose limit to the spinal cord. 
MLC-based IMRT
MLC-based IMVAT (RapidArc © , Varian Medical Systems, Palo Alto, CA, USA) (21) and traditional MLC fixed-beam IMRT delivery were also investigated. For IMVAT, all treatment plans were developed using a Varian Eclipse research treatment planning system. A 6 MV beam was selected for the Novalis TX Clinac (BrainLab, AG, Munich, Germany and Varian Medical Systems, Palo Alto, CA, USA) equipped with a 120 leaf MLC. The leaves are characterized by a spatial resolution of 2.5 mm at isocenter. Inverse planning for RapidArc is an interactive process in which all objectives can be modified at all times during the optimization, and we reference the following papers that describe the method and quality assurance aspects for interested readers (21, (28) (29) (30) (31) (32) .
In brief, the optimization algorithm searches the shape and monitor units (MU) for each MLC segment using an aperture based approach (21) . Both the MLC leaf position and dose rate change with gantry rotation. Treatment planning starts with a small number of beam samples (control points or gantry directions), and adds more samples during the optimization. A maximum dose rate of 600 MU/minute with delivery of a single 360 o arc was selected for this study, and the final plan contains 177 control points. Multiple arcs with different couch and collimator positions are available but were not investigated in this study.
For fixed-beam IMRT delivery, treatment plans were developed with user-selected coplanar or non-coplanar beam angles (~8-11 beam angles), and with MLC systems possessing leaf widths of 2.5 mm (BrainLab, AG, Munich, Germany and Varian Medical Systems, Palo Alto, CA, USA), 4 mm (Elekta Synergy, Crawley, UK) and 5 mm (Varian Medical Systems, Palo Alto, CA, USA). For the BrainLab and all Varian systems, with one exception, beams were equally spaced at 15° or 20° intervals starting from 0° or 10° of the gantry vertical position (e.g. 10°, 15°, 30°, etc). Of note, treatment planning was performed by one institution with a non-coplanar beam arrangement with gantry angles of 0°, 4°, 22°, 37°, 82°, 322°, 252°, 359°, corresponding to couch angles of 340°, 358°, 330°, 83°, 40°, 338°, and 5°, respectively (Table I) . All plans were developed using commercially available inverse optimization systems (Phillips P 3 IMRT or Varian Eclipse) with no preset control points for dynamic or "sliding window" delivery except for the Elekta Synergy system where Direct Machine Parameter Optimization (DMPO) was used with a minimum equivalent segment area of 2 cm 2 . DMPO is commonly referenced in Pinnacle treatment planning to describe the direct optimization of the position of the MLC leaves and jaws for each step-and shoot IMRT segment, and the beam weight of these segments. The area of the segments is commissioned to a minimum equivalent-square of 2 cm 2 as a balance between complexity in beamlet optimization and acceptable measured-to-calculated dose agreement for
The rationale for using an increasing number of adjacent VBs as PTVs for benchmark planning, lies in allowing the length of spinal cord and esophagus adjacent to the PTV to increase proportionally with the PTV length. As a result, maintaining the same low dose to a small absolute volume, such as 0.1 cc of the spine cord or the esophagus, becomes increasingly difficult as greater volumes of the PTVs are irradiated to the same high dose. In essence, varying the number of consecutive VBs served as a convenient and effective tool for increasing plan complexity. The use of consecutive VB cases for benchmarking different modalities was also based on the considerations that: (1) the dose constraints need to be general enough to be applicable to all modalities that go beyond conventional linac-based photon-beam system (23) and (2) it builds on our previously published experiences on spine SBRT (24, 25) .
In order to make comparisons, all treatment plans for the study were normalized such that 95% of the planning target volume (PTV) received 100% of the prescribed dose (D95 = 24 Gy). Based on this normalization, we then set a cut-off of ≥2% variation on the strict dose constraints as specified for the spinal cord and esophagus to determine any trends in each technology's capabilities. The planning strategies and hardware configurations are summarized in Table I .
Cyberknife
All Cyberknife plans were generated using non-isocentric circular 6 MV beams with diameters ranging from 5 mm to 15 mm from a large number (~200-400) of beam angles, mostly directed from the anterior hemisphere. We adopted a mixture of cones for planning these cases and tested out a large number if not all possible combinations before finalizing the plan. We did observe that mixing the 5 mm cones with other cone sizes (10, 12.5 and 15 mm) significantly improved the dose gradient fall-off near spinal cord, although at the expense of treatment time and possibly dose inhomogeneity. Since this study was focused on exploring the physical limits of each modality, the best plan was determined independent of treatment time. Cyberknife treatment plans were developed using an inverse treatment planning system (MultiPlan version 3.5, Accuray Inc. Sunnyvale, CA) that optimizes the beam direction and relative weights of each beam (19) . In order to examine potential effects related to the planning software, all Cyberknife treatment plans were generated in two ways: (1) by using the iterative optimization routine, where the optimization parameters for the objective function were iteratively adjusted, and (2) by using the most recent sequential optimization routine (26) . Both routines are available for common Cyberknife clinical practices (27) .
cord, and esophagus, respectively. From the results of Figure  2a -c, it is apparent that dose homogeneity varied significantly among these modalities, with the Cyberknife plans exhibiting the most heterogeneity. In contrast, IMP and the 2.5 mm MLC based plans produced the most homogeneous treatment plans with the lowest maximum dose to prescription dose ratio (MDPD), as well as the lowest dose to 1% of the PTV receiving the highest dose (PTV D1). At lower dose levels, such as dose to 1 cc of the spinal cord IMP, non-isocentric Cyberknife as well as IMRT using a high number of beams (>8, including RapidArc) and with fine MLC widths (2.5 mm) tended to show more sparing. This result was also consistent for the esophagus as shown in Figure 2c . Analogous results for the two-and three-VB plans are shown in Figures 3a-c and 4a-c. From these figures, the most apparent effect is the variation in the target dose hot spots, particularly evident for the Cyberknife. This is expected given that Cyberknife currently uses fixed-size mechanical cones with beam apertures. Therefore, as the target volume is enlarged, the planner may only increase the number of beams rather than enlarging and conforming the aperture sizes to maintain an acceptable dose fall-off in the cord and esophagus. The increased overlapping of many cross-firing beams can create substantial dose hot spots, as demonstrated by the elevated MDPD ratios in Table II .
In contrast, MLC-based IMRT systems exhibited significantly smaller increases in dose hot spots and in the MDPD ratio, due to the flexibility of varying beam apertures with moving jaws or MLC leaf pairs. For the three-VB case, treatment plans created with the 2.5 mm leaf width MLC (IMVAT and IMRT) yielded nearly identical target dose inhomogeneity, and similar or better critical structure sparing as compared with IMP plans. From the results of Table  II , treatment plans created with coarser leaf widths such as 4 and 5-mm MLC leaves produced notably more violations than with a 2.5 mm leaf width (Table II is listed in the order of such violations), however, the treatment planning systems were not the same (Pinnacle system as opposed to the Eclipse system for the latter). When mean differences in dosimetric parameters amongst the one-, two-and three-VB groups for all modalities were compared via t-test, no statistically significant differences were found (p > 0.05 for all comparisons). No intra-group analysis was conducted due to singularity of studied variables from each institution case.
Discussion
Our study represents an extensive comparative dosimetric investigation of some of the commercially available technologies suitable for spine SBRT. Proton IMP plans were also generated, but this technology is available only on a research platform and, therefore, not currently in use for spine SBRT.
patient-specific IMRT quality assurance. Depending on the machine dose rate (e.g. 300-1000 MU/min) of individual institutions, the total number of segments (or control points) for all plans ranged from approximately 60 to 200. Important to note, treatment planning was achieved with the Varian Eclipse system for the 2.5-mm MLC IMRT plans (fixed field and IMVAT), and with the Phillips Pinnacle system (Philips Medical Systems, Madison, WI) for the 4-and 5-mm MLC IMRT systems.
Intensity-Modulated Protons
For IMP treatment planning, three fixed intensity modulated beams (gantry angle of 0°, 47° and 207°) were utilized. A generic proton beam line was used that was not tailored to any clinical facility or specific commercial system. It was characterized by allowing beam spot scanning and intensity modulation capabilities through inverse planning optimization via tuning the spot energy and beam weights simultaneously.
The basic workflow for IMP treatment planning was as follows: (1) calculation of the beam line settings (including spot list containing the spot positions and a set of start weights for the spots) (2) optimization of the spot weights, (3) postprocessing of the spot list (where a deliverable spot scanning sequence was generated) and (4) final dose calculation via summing all the scanning layers accounting for differences in tissue properties within the patient. Because there is range uncertainty with protons, we applied "robust planning'' to use three fields that avoid abutting directly against the main organ-at-risk (in this case the spinal cord) (33) .
Results
Prior to normalization, all tested modalities satisfied the spinal cord constraint with PTV coverage >90%. All plans were then normalized such that 100% of the prescription dose (24 Gy) covered 95% of the PTV (D95 = 24 Gy). A deviation threshold of >2% variation on the stated strict dose limits for the organs at risk, spinal cord and esophagus maximum point dose and 0.1 cc dose, was implemented in order to highlight potential differences in the technologies. The D1 cc for the esophagus and spinal cord were also described to illustrate the effects at larger volumes, however, this was not a parameter to consider in treatment planning. In general, all institutions developed clinically acceptable plans. Following normalization, the data are summarized in Tables IIa-IIc, and normalized dose volume histograms for the single, two, and three VB treatment plans are provided in Figures 2a-c, 3a -c and 4a-c, respectively.
For the single VB treatment plans, normalized dose volume histograms are given in Figure 2 where Figure 2a, 2b, First, a large number of non-isocentric Cyberknife beams produced treatment plans that readily satisfied constraints to the organs at risk in all cases, though, at the expense of target dose heterogeneity and increased number of beams. Our study also determined the degree of heterogeneity within
Overall, we found that all modalities are capable of generating acceptable plans that satisfy strict benchmark dose-volume constraints. However, with all plans identically normalized to ensure dosimetric comparability, certain trends were noted based on the results of our study (Table IIa- beam arrangements, the data suggest that a smaller leaf width MLC (2.5 mm) in conjunction with a high number of beams (e.g. >8) is favored over larger MLC leaf widths and fewer beams, and IMVAT with a 2.5 mm MLC offered the PTV to be substantially decreased with the new sequential optimization treatment planning algorithm, though, it remains the highest amongst the modalities investigated. For MLC-based IMRT delivery, using fixed co-planar favorable results when compared to the other modalities.
Although the clinical applications of IMP for spine SBRT have yet to be reported, this study demonstrates the dosimetric potential for IMP, however, no specific advantage was concluded upon as compared to the modalities investigated in this report.
More specifically, Cyberknife tended to create the highest dose hot spots within the target while the IMVAT (RapidArc © ) and IMP tended to create the most homogenous treatment plans. In theory, target dose hot spots potentially may be either advantageous because of the increased biologically effective dose (BED) within the target, or disadvantageous because of in sparing a serial structure such as the spinal cord, and small translational and rotational errors during spine SBRT have shown to influence the actual dose delivered to the spinal cord (3, 7, 22, 36, 37) . At lower dose levels such as dose to 1 cc of the spinal cord, the IMP, non-isocentric Cyberknife and fixed field IMRT using a high number of beams (including RapidArc) with 2.5 mm MLC leaf width tended to show more sparing. The clinical significance of minimizing low an increased risk of bone fracture (34, 35) . Additionally, the disadvantage of extreme high dose regions within the target is the extreme demand for rigorous precision in delivery and patient setup accuracy. The consequence may be more severe if the dose distribution is inadvertently shifted into an adjacent critical structure as compared to a more homogeneous plan. This is especially important for spine SBRT, where the dose to a small volume can be critically important dose exposure within the spinal cord for a given high dose exposure to a small volume is questionable. Recent rodent proton beam data suggests that the low dose exposure can impact the spinal cord tolerance to within the high dose volume, implying clinical significance (38) . However, this finding has yet to be substantiated in pigs and humans according to recent reports (39, 40) .
Evaluation specific to the IMRT treatment plans provides information as to potential benefits for smaller leaf widths (2.5 mm), as opposed to larger leaf width MLCs (4 mm and 5 mm). However, direct comparison is cautioned given that we did not investigate the accuracy of the treatment plan delivery. Furthermore, the 4-mm and 5-mm treatment plans were based on the Pinnacle algorithm while the 2.5 mm IMRT and RapidARC plans based on the Eclipse AAA convolution superposition algorithm (41) . In looking at the target DVHs in Figures 2 to 4 , we note that the 4 and 5 mm MLC plans changed in a similar fashion as the complexity of the case increased (i.e. number of VBs increased). The 2.5 mm fixed field IMRT plans appear to result in better dose distributions, and also performed similarly to the IMVAT plans with a 2.5 mm MLC. We also observed that single-arc IMVAT plans did not show improved target coverage, or spinal cord and esophagus sparing, when compared to the static IMRT treatment plans of the same leaf width based on the 2.5 mm MLC. Of note, we did not evaluate multiple-arc IMVAT planning, and a recent study from Wu et al. suggested that two-arc-VMAT may yield dosimetric advantages over a single-arc delivery for spine SBRT (20) . This is an area of further investigation given that this technology has only begun to emerge into mainstream radiation oncology. Overall, these data can only suggest that as leaf width decreases that the treatment plan quality increases, however, planning of each case on both Pinnacle and Eclipse systems with a direct comparison would be required to yield conclusive results.
Other investigators have also demonstrated that a finer leaf size results in better treatment plans for SBRT targets. For example, Wu et al (42) recently compared SBRT plans with 2.5 mm versus 5 mm MLC leaf size based on the Eclipse treatment planning system for the Novalis TX (BrainLab AG, Munich, Germany and Varian Medical Systems, Palo Alto, CA, USA) platform, and reported dosimetric benefits with the finer leaf size. Likewise, Chang et al. (43) reported benefits to finer MLC leaf widths (5 mm vs. 3 mm leaf size) within the Varian platform. The consistency of the treatment planning system in these studies support the observation that finer leaf size may be advantageous, however, in our study similar conclusions can only be suggested given the lack of uniformity in the treatment planning system. We did find that the results for the 2.5 mm MLC IMRT plans were consistent, as they were planned independently at two different institutions yielding similar results.
Limitations to this study include the inability to directly evaluate delivery accuracy and precision, and we relied on dose calculation accuracy and the optimization algorithms specific to each treatment planning platform. We emphasize that future algorithms may lead to different results. Additionally, the analysis may also depend on the dose grid size being utilized which ranged from 0.5 mm for the Cyberknife, 2 mm for the RapidArc and IMP systems and from 2 to 4 mm for the photon beam IMRT systems evaluated. Varying grid size may also impact IMRT treatment plan optimization as well as DVH calculations, where an estimate of 10-15% in uncertainties have been reported by other investigators (44) . This is further suggested by a previous study (41) , and clearly indicated by our observed results with the comparison of the Cyberknife treatment plans based on the older and the new treatment planning algorithm. Compared to the iterative algorithm, the new Cyberknife sequential optimization algorithm yielded significantly more homogenous treatment plans and lower D 1 and D 5 (dose to 1% and 5% of the volume, respectively) values within the PTV, for each PTV investigated. The same discussion also applies to other systems including linac-based IMRT systems, where optimization algorithms and user experience may influence the results of the study despite extensive practical experiences of the participants. Given that all institutions exercised maximum freedom and capability for satisfying the designed planning constraints, it is possible that variations in the subjective choice, or clinical discretions, such as beam orientations and beam numbers etc. may affect the quality of observed plans.
It was impractical for us to evaluate every possible modality in this study. For example, TomoTherapy (TomoTherapy Inc., Wisconsin, USA), a commonly used modality, was not evaluated in this study, although this technology has been reported in the practice of spine SBRT (45) . We encourage other investigators to perform a similar study with this technology.
Conclusion
For complex spine SBRT treatment planning, we determined that each technology overall yielded dosimetric feasibility. However, MLC-based IMRT with fine leaf widths and multiple fields yielded optimal treatment plans to satisfy the constraints set for this treatment planning study. It was also observed that (1) IMVAT (RapidArc) with a 2.5 mm MLC yielded plans equivalent to those of 2.5 mm fixed-beam IMRT delivery, (2) Cyberknife plans optimally spared critical structures at the expense of increased dose heterogeneity and (3) IMP treatment plans are feasible but do not appear to yield benefits over current best photon-beam IMRT plans, at least within the scope of this study. These findings are limited in that delivery was not tested and treatment planning systems were not uniformly standardized.
